58 related articles for article (PubMed ID: 16506211)
1. Frequency and resistance of CD95 (Fas/Apo-1) gene-transfected tumor cells to CD95-mediated apoptosis by the elimination and methylation of integrated DNA.
Shimizu M; Yoshimoto T; Sato M; Matsuzawa A; Takeda Y
Int J Cancer; 2006 Aug; 119(3):585-92. PubMed ID: 16506211
[TBL] [Abstract][Full Text] [Related]
2. Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer.
Shimizu M; Yoshimoto T; Matsuzawa A; Takeda Y
Mol Biotechnol; 2003 Sep; 25(1):79-87. PubMed ID: 13679638
[TBL] [Abstract][Full Text] [Related]
3. A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo.
Shimizu M; Yoshimoto T; Nagata S; Matsuzawa A
Biochem Biophys Res Commun; 1996 Nov; 228(2):375-9. PubMed ID: 8920922
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
Müller M; Strand S; Hug H; Heinemann EM; Walczak H; Hofmann WJ; Stremmel W; Krammer PH; Galle PR
J Clin Invest; 1997 Feb; 99(3):403-13. PubMed ID: 9022073
[TBL] [Abstract][Full Text] [Related]
5. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
6. Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
Watson CJ; O'Kane H; Maxwell P; Sharaf O; Petak I; Hyland PL; O'Rouke D; McKnight J; Canning P; Williamson K
Int J Oncol; 2012 Mar; 40(3):645-54. PubMed ID: 22076446
[TBL] [Abstract][Full Text] [Related]
7. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
10. Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation.
Walker PR; Calzascia T; Schnuriger V; Chalmers D; Saas P; Dietrich PY
Cell Immunol; 2000 Nov; 206(1):51-8. PubMed ID: 11161437
[TBL] [Abstract][Full Text] [Related]
11. Fas (CD95, APO-1) antigen expression and function in murine mast cells.
Hartmann K; Wagelie-Steffen AL; von Stebut E; Metcalfe DD
J Immunol; 1997 Oct; 159(8):4006-14. PubMed ID: 9378990
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
Quirk SM; Porter DA; Huber SC; Cowan RG
Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
[TBL] [Abstract][Full Text] [Related]
14. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.
Barnhart BC; Pietras EM; Algeciras-Schimnich A; Salmena L; Sayama K; Hakem R; Peter ME
Cell Death Differ; 2005 Jan; 12(1):25-37. PubMed ID: 15499374
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
Mishima K; Nariai Y; Yoshimura Y
Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody.
Durandy A; Le Deist F; Emile JF; Debatin K; Fischer A
Eur J Immunol; 1997 Feb; 27(2):538-43. PubMed ID: 9045928
[TBL] [Abstract][Full Text] [Related]
18. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells.
Yang D; Thangaraju M; Greeneltch K; Browning DD; Schoenlein PV; Tamura T; Ozato K; Ganapathy V; Abrams SI; Liu K
Cancer Res; 2007 Apr; 67(7):3301-9. PubMed ID: 17409439
[TBL] [Abstract][Full Text] [Related]
19. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
20. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
